U.S. approves two ‘breakthrough’ gene therapies for sickle cell treatment

The United States Food and Drug Administration (FDA) has, on Friday, approved a therapy called Casgevy made by Vertex Pharmaceuticals and CRISPR Therapeutics for the treatment of sickle cell disease.
According to NBC News, it is the first medicine that uses the gene-editing tool CRISPR to be approved for treatment of sickle cell in the United States. In 2020, the investors of the treatment method won the Nobel Prize in chemistry.
Sickle cell disease is an hereditary blood disorder passed from parents to their children that reduces the lifespan of the red blood cells, causing anemia with more than 120 million people suffering from it worldwide.
According to the World Health Organisation (WHO), more than 66 per cent of sickle cell patients live in Africa. About 1,000 children born daily in the region carry the disease, making it the most prevalent genetically-acquired disease in the region.
Also, the FDA approved another sickle cell disease treatment called Lyfgenia, a gene therapy produced by drugmaker Bluebird Bio. The two approved treatments work by genetically modifying a patient’s own stem cells, NBC reported.
Until now, bone marrow transplant was the only method for treatment of sickle cell disease but the treatment is a difficult process due to risk of rejection by the immune system of the recipient and the scarcity when looking for a matching donor.
“I think this is a pivotal moment in the field,” Dr Alexis Thompson, chief of the division of hematology at Children’s Hospital of Philadelphia, who has previously consulted for Vertex, was quoted by NBC.
He added: “It’s been really remarkable how quickly we went from the actual discovery of CRISPR, the awarding of a Nobel Prize, and now actually seeing it being an approved product.”
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette

States
Independence: NBA urges Nigerians to expect better future
The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.

Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”

World
Nine U.S. states experience extreme weather linked to El Niño
U.S. NOAA said last week that El Niño was strengthening and was likely to remain strong to very strong through March 2027.

Africa
WHO urges African countries to intensify fight against antimicrobial resistance
The WHO regional director for Africa said bacterial antimicrobial resistance was associated with an estimated 4.7 million deaths globally in 2021.

NationWide
Nigeria ranks fifth as Canada approved 816,745 visitor visas in eight months
Of the total, Nigeria accounted for 26,210, ranking fifth among the countries with the highest number of approved visas.

States
Gully erosion threatens power transmission structure in Cross River
The director-general, CR-SEMA, Efa Nyong, said the ravaging gully was threatening a major high-tension electricity transmission.

States
Court remands teenager for igniting fire at filling station in attempted suicide
Mr Alimodu was charged with unlawful attempt to kill oneself and malicious damage.

States
Kogi Senatorial Ticket: Court strikes out suit challenging Yahaya Bello’s candidacy
Mr Bello’s lawyer, Paul Daudu, said the court could not give Mr Obaro’s documents “probative value in law.”





